DTIL
Price
$7.17
Change
-$0.07 (-0.97%)
Updated
Sep 11 closing price
Capitalization
197.9M
59 days until earnings call
Intraday BUY SELL Signals
VKTX
Price
$31.98
Change
-$0.15 (-0.47%)
Updated
Sep 11 closing price
Capitalization
3.73B
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DTIL vs VKTX

DTIL vs VKTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DTIL vs. VKTX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTIL is a StrongBuy and VKTX is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($3.73B) has a higher market cap than DTIL($198M). DTIL YTD gains are higher at: 72.356 vs. VKTX (-9.096). DTIL has higher annual earnings (EBITDA): -49.7M vs. VKTX (-559.57M). VKTX has more cash in the bank: 502M vs. DTIL (87.5M). VKTX has less debt than DTIL: VKTX (4.09M) vs DTIL (28.1M). DTIL has higher revenues than VKTX: DTIL (45.1M) vs VKTX (0).
DTILVKTXDTIL / VKTX
Capitalization198M3.73B5%
EBITDA-49.7M-559.57M9%
Gain YTD72.356-9.096-795%
P/E Ratio4.53N/A-
Revenue45.1M0-
Total Cash87.5M502M17%
Total Debt28.1M4.09M688%
FUNDAMENTALS RATINGS
DTIL vs VKTX: Fundamental Ratings
DTIL
VKTX
OUTLOOK RATING
1..100
6470
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
49
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
4150
P/E GROWTH RATING
1..100
99100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (49) in the Biotechnology industry is in the same range as DTIL (56). This means that VKTX’s stock grew similarly to DTIL’s over the last 12 months.

VKTX's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as DTIL (100). This means that VKTX’s stock grew similarly to DTIL’s over the last 12 months.

VKTX's SMR Rating (98) in the Biotechnology industry is in the same range as DTIL (99). This means that VKTX’s stock grew similarly to DTIL’s over the last 12 months.

DTIL's Price Growth Rating (41) in the Biotechnology industry is in the same range as VKTX (50). This means that DTIL’s stock grew similarly to VKTX’s over the last 12 months.

DTIL's P/E Growth Rating (99) in the Biotechnology industry is in the same range as VKTX (100). This means that DTIL’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DTILVKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 23 days ago
78%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 3 days ago
86%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (DTIL: $7.17 vs. VKTX: $31.98)
Brand notoriety: DTIL and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DTIL: 61% vs. VKTX: 115%
Market capitalization -- DTIL: $197.9M vs. VKTX: $3.73B
DTIL [@Biotechnology] is valued at $197.9M. VKTX’s [@Biotechnology] market capitalization is $3.73B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DTIL’s FA Score shows that 0 FA rating(s) are green while VKTX’s FA Score has 0 green FA rating(s).

  • DTIL’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than DTIL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DTIL’s TA Score shows that 3 TA indicator(s) are bullish while VKTX’s TA Score has 2 bullish TA indicator(s).

  • DTIL’s TA Score: 3 bullish, 7 bearish.
  • VKTX’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, both DTIL and VKTX are a bad buy in the short-term.

Price Growth

DTIL (@Biotechnology) experienced а -4.02% price change this week, while VKTX (@Biotechnology) price change was -8.29% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

DTIL is expected to report earnings on Nov 10, 2026.

VKTX is expected to report earnings on Oct 28, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DTIL
Daily Signal:
Gain/Loss:
VKTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEQFX19.38N/A
N/A
AMG River Road Large Cap Value Select I
FMXSX9.04N/A
N/A
Federated Hermes Max-Cap Index Svc
FITIX26.20N/A
N/A
Fidelity Advisor Mid Cap II M
CSCIX15.11N/A
N/A
Cohen & Steers Real Estate Securities C
MXETX14.54N/A
N/A
Empower Core Strategies US Eq Inv

DTIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, DTIL has been loosely correlated with AXON. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DTIL jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DTIL
1D Price
Change %
DTIL100%
-0.97%
AXON - DTIL
46%
Loosely correlated
+0.10%
EDIT - DTIL
45%
Loosely correlated
+1.89%
ORMP - DTIL
41%
Loosely correlated
-2.10%
VKTX - DTIL
40%
Loosely correlated
-0.47%
ARRY - DTIL
39%
Loosely correlated
+1.54%
More